Seroquel For Bipolar Depression: The BOLDest and Best?
The Carlat Psychiatry Report, Volume 8, Number 5, May 2010
https://www.thecarlatreport.com/newsletter-issue/tcprv8n5/
Issue Links: Learning Objectives | Editorial Information
Topics: Bipolar Disorder
Section editor, Glen Spielmans, PhD
In 2005 and 2006, two trials showed a substantial advantage for quetiapine (Seroquel) over placebo for bipolar depression. Based on these trials, which were known by the acronym BOLDER I and II, quetiapine received an FDA indication for the condition.
You can't view details of this content, please login or buy subscription here
Section editor, Glen Spielmans, PhD
Glen Spielmans, PhD, has disclosed that he has no relevant financial or other interests in any commercial companies ertaining to this educational activity.